Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Immix Biopharma, Inc.IMMX · Entity 4958 | Director · CEO and Chairman | May 22, 2026 | May 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Immix Biopharma, Inc.
Report date May 22, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.78 · Expires 2036-05-22 | Direct | 500,000 |
Reported balance
After 2026-05-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-22 · Grant · Acquired 500,000 · Balance 500,000 F1: The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2026 Filed May 29, 2026 21:05 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001493152-26-026425 · ownership.xml · derivative · entry 1 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2036-05-22 F1 · derivative.exercise_date: The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| December 10, 2025 Filed Dec 10, 2025 23:49 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | PurchaseCommon Stock | 746 | $6.67 | $4,975.82 |
DisclosureSEC source: 0001493152-25-027109 · ownership.xml · nonDerivative · entry 1 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,141,683 Read SEC document |
| September 17, 2025 Filed Sep 17, 2025 21:20 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | PurchaseCommon Stock | 2,500 | $2.02 | $5,050.00 |
DisclosureSEC source: 0001493152-25-013919 · ownership.xml · nonDerivative · entry 1 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,140,937 F1 · price: Volume-weighted average price of purchases which transactions occurred at purchase prices from $2.01 to $2.02 per share, inclusive. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 20, 2025 Filed Jun 23, 2025 20:57 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | GrantStock Option (Right to Buy) · Derivative | 340,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001641172-25-016116 · ownership.xml · derivative · entry 2 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,000 Underlying: Common Stock · 340,000 shares Expires 2035-06-20 F1 · derivative.exercise_date: The Stock Option will vest in forty-eight (48) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 13:35 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | PurchaseCommon Stock | 2,178 | $2.30 | $4,998.51 |
DisclosureSEC source: 0001641172-25-015756 · ownership.xml · nonDerivative · entry 1 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,138,437 F1 · price: Volume-weighted average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 11, 2024 Filed Jun 21, 2024 21:45 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | GrantStock Option (Right to Buy) · Derivative | 340,000 | $0.00 Strike: $2.04 | $0.00 |
DisclosureSEC source: 0001493152-24-024828 · ownership.xml · derivative · entry 2 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,000 Underlying: Common Stock · 340,000 shares Expires 2034-06-11 F1 · derivative.exercise_date: The Stock Option will vest in 48 equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 13:00 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | PurchaseCommon Stock | 2,600 | $2.13 | $5,538.00 |
DisclosureSEC source: 0001493152-24-023287 · ownership.xml · nonDerivative · entry 1 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,136,259 Read SEC document |
| June 04, 2024 Filed Jun 5, 2024 13:00 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | PurchaseCommon Stock | 3,300 | $1.81 | $5,970.03 |
DisclosureSEC source: 0001493152-24-022653 · ownership.xml · nonDerivative · entry 1 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,133,659 Read SEC document |
| May 20, 2024 Filed May 20, 2024 21:25 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | GrantCommon Stock | 218,359 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-24-020778 · ownership.xml · nonDerivative · entry 1 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,130,359 F1 · price: Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity. Read SEC document |
| May 14, 2024 Filed May 15, 2024 01:28 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | PurchaseCommon Stock | 4,300 | $2.25 | $9,659.95 |
DisclosureSEC source: 0001493152-24-019366 · ownership.xml · nonDerivative · entry 1 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 912,000 Read SEC document |
| August 14, 2023 Filed Nov 10, 2023 00:54 UTC Amendment | Immix Biopharma, Inc. IMMX · Entity 4958 | GrantStock Options · Derivative | 293,000 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001493152-23-040172 · ownership.xml · derivative · entry 1 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,000 Underlying: Common Stock · 293,000 shares Expires 2033-08-14 F1 · derivative.exercise_date: Options vest monthly over 48 months from the date of grant. Read SEC document |
| August 11, 2023 Filed Aug 14, 2023 20:15 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | GrantStock Options · Derivative | 193,000 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001493152-23-028470 · ownership.xml · derivative · entry 1 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,000 Underlying: Common Stock · 193,000 shares Expires 2033-08-11 F1 · derivative.exercise_date: Options vest monthly over 48 months from the date of grant. Read SEC document |
| November 14, 2022 Filed Nov 15, 2022 22:33 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | PurchaseCommon Stock | 150 | $0.99 | $148.50 |
DisclosureSEC source: 0001493152-22-032557 · ownership.xml · nonDerivative · entry 3 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 907,700 Read SEC document |
| November 14, 2022 Filed Nov 15, 2022 22:33 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | PurchaseCommon Stock | 1,000 | $0.95 | $950.00 |
DisclosureSEC source: 0001493152-22-032557 · ownership.xml · nonDerivative · entry 2 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 907,550 Read SEC document |
| November 14, 2022 Filed Nov 15, 2022 22:33 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | PurchaseCommon Stock | 4,050 | $1.02 | $4,126.95 |
DisclosureSEC source: 0001493152-22-032557 · ownership.xml · nonDerivative · entry 1 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 906,550 Read SEC document |
| July 14, 2022 Filed Jul 18, 2022 10:09 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | GrantStock Options · Derivative | 250,000 | $0.00 Strike: $2.64 | $0.00 |
DisclosureSEC source: 0001493152-22-019509 · ownership.xml · derivative · entry 1 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520,000 Underlying: Common Stock · 250,000 shares Expires 2032-07-14 F1 · derivative.exercise_date: Options vest monthly in equal amounts over 48 months. Read SEC document |
| December 20, 2021 Filed Dec 20, 2021 21:15 UTC | Immix Biopharma, Inc. IMMX · Entity 4958 | PurchaseCommon Stock | 2,500 | $5.00 | $12,500.00 |
DisclosureSEC source: 0001493152-21-032038 · ownership.xml · nonDerivative · entry 1 Rachman Ilya M · CIK 0001889334 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 902,500 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.